Serum epidermal growth factor predicts cognitive functions in early, drug-naive Parkinson's disease patients (Q38465589)

3 September 2017

title

Serum epidermal growth factor predicts cognitive functions in early, drug-naive Parkinson's disease patients (English)

1 reference

3 September 2017

1 reference

Annamaria Colao

1 reference

3 September 2017

Rosario Pivonello

1 reference

3 September 2017

Paolo Barone

1 reference

3 September 2017

Carmine Vitale

1 reference

3 September 2017

Marina Picillo

1 reference

3 September 2017

Gabriella Santangelo

1 reference

3 September 2017

Maria Teresa Pellecchia

object named as

Maria Teresa Pellecchia

1 reference

3 September 2017

Marianna Amboni

1 reference

3 September 2017

Katia Longo

1 reference

3 September 2017

Claudia Pivonello

1 reference

3 September 2017

Anna De Rosa

1 reference

3 September 2017

Marcello Moccia

1 reference

3 September 2017

Roberto Erro

1 reference

3 September 2017

Giuseppe De Michele

1 reference

3 September 2017

Lucio Santoro

1 reference

3 September 2017

publication date

22 August 2012

1 reference

3 September 2017

1 reference

3 September 2017

volume

260

1 reference

3 September 2017

1 reference

3 September 2017

page(s)

438-444

1 reference

Cognitive profile of patients with newly diagnosed Parkinson disease.

3 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6648-6

Mild Cognitive Impairment in Parkinson’s Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6648-6

Risk of dementia in Parkinson's disease: a community-based, prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6648-6

The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6648-6

Is quality of life in non-demented Parkinson's disease patients related to cognitive performance? A clinic-based cross-sectional study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6648-6

Influences of dopaminergic lesion on epidermal growth factor-ErbB signals in Parkinson's disease and its model: neurotrophic implication in nigrostriatal neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6648-6

Intraventricular infusion of epidermal growth factor restores dopaminergic pathway in hemiparkinsonian rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6648-6

Dopamine-induced proliferation of adult neural precursor cells in the mammalian subventricular zone is mediated through EGF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6648-6

Neurogenesis in hippocampal slice cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6648-6

Long-term effects of cytokine treatment on cognitive behavioral recovery and neuronal regeneration in soman-poisoned mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6648-6

Central role of the EGF receptor in neurometabolic aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6648-6

Heparin-binding EGF-like growth factor is required for synaptic plasticity and memory formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6648-6

A strain-independent postnatal neurodegeneration in mice lacking the EGF receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6648-6

Neuronal survival depends on EGFR signaling in cortical but not midbrain astrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6648-6

Plasma epidermal growth factor levels predict cognitive decline in Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6648-6

Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6648-6

Clinical diagnostic criteria for dementia associated with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6648-6

Systematic review of levodopa dose equivalency reporting in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6648-6

Evaluation of a previously suggested plasma biomarker panel to identify Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6648-6

Five out of 16 plasma signaling proteins are enhanced in plasma of patients with mild cognitive impairment and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6648-6

A meta-analytic review of verbal fluency performance following focal cortical lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6648-6

A systematic review and quantitative appraisal of fMRI studies of verbal fluency: role of the left inferior frontal gyrus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6648-6

Colour perception in ADHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6648-6

A common neural substrate for perceiving and knowing about color

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6648-6

Rapid stimulation of amyloid precursor protein release by epidermal growth factor: role of protein kinase C

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6648-6

Localization of immunoreactive epidermal growth factor receptors in human nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6648-6

The FAB: a Frontal Assessment Battery at bedside.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6648-6

The Mental Deterioration Battery: normative data, diagnostic reliability and qualitative analyses of cognitive impairment. The Group for the Standardization of the Mental Deterioration Battery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6648-6

Rey-Osterrieth complex figure: normative values in an Italian population sample

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6648-6

Trail making test: normative values from 287 normal adult controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6648-6

Visuospatial judgment. A clinical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6648-6

A normative study on visual reaction times and two Stroop colour-word tests

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22911513

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Neuromodulation by polypeptide growth factors: preliminary results on the distribution of epidermal growth factor receptors in adult brain.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22911513

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Effect of intracerebroventricular infusion of epidermal growth factor in rats hemitransected in the nigro-striatal pathway

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22911513

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S00415-012-6648-6

1 reference

Dimensions Publication ID

3 September 2017

1017081040

0 references

1 reference